Ganapathi Iyer Parameswaran1, Sanjay Sethi2, Timothy F Murphy3. 1. Division of Infectious Diseases, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY; VA Western New York Healthcare System, Buffalo, NY. Electronic address: gp36@buffalo.edu. 2. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY; VA Western New York Healthcare System, Buffalo, NY. 3. Division of Infectious Diseases, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY; Division of Microbiology, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY.
Abstract
BACKGROUND: Pathogenic bacteria colonize the airways of 30% to 40% of patients with COPD and cause approximately 50% of exacerbations. New strains of nontypeable Haemophilus influenzae (NTHI) and Moraxella catarrhalis are associated with exacerbations. Antimicrobial protein/peptides (AMPs) play important roles in innate lung defense against pathogens. To our knowledge, the changes in AMP baseline levels in respiratory secretions during bacterial colonization and exacerbation have not been described. The objective of this study was to elucidate the effects of the acquisition of a new strain of pathogenic bacteria on the airway levels of AMPs in patients with COPD. METHODS: One hundred fifty-three samples from 11 patients were selected from COPD sputum samples collected prospectively over 6 years. Samples were grouped as culture-negative (no pathogenic bacteria), colonization, and exacerbation due to new strains of NTHI and M catarrhalis. Levels of lysozyme, lactoferrin, LL-37, and secretory leukocyte protease inhibitor (SLPI) were measured by enzyme-linked immunosorbent assay and compared among groups by paired analysis. RESULTS: Compared with baseline, sputum lysozyme levels were significantly lower during colonization and exacerbation by NTHI (P = .001 and P = .013, respectively) and M catarrhalis (P = .007 and P = .018, respectively); SLPI levels were lower with exacerbation due to NTHI and M catarrhalis (P = .002 and P = .004, respectively), and during colonization by M catarrhalis (P = 032). Lactoferrin levels did not change significantly; LL-37 levels were higher during exacerbation by NTHI and M catarrhalis (P = .001 and P = .018, respectively). CONCLUSIONS: Acquisition of NTHI and M catarrhalis is associated with significant changes in airway levels of AMPs, with larger changes in exacerbation. Airway AMP levels are likely to be important in pathogen clearance and clinical outcomes of infection in COPD.
BACKGROUND: Pathogenic bacteria colonize the airways of 30% to 40% of patients with COPD and cause approximately 50% of exacerbations. New strains of nontypeable Haemophilus influenzae (NTHI) and Moraxella catarrhalis are associated with exacerbations. Antimicrobial protein/peptides (AMPs) play important roles in innate lung defense against pathogens. To our knowledge, the changes in AMP baseline levels in respiratory secretions during bacterial colonization and exacerbation have not been described. The objective of this study was to elucidate the effects of the acquisition of a new strain of pathogenic bacteria on the airway levels of AMPs in patients with COPD. METHODS: One hundred fifty-three samples from 11 patients were selected from COPD sputum samples collected prospectively over 6 years. Samples were grouped as culture-negative (no pathogenic bacteria), colonization, and exacerbation due to new strains of NTHI and M catarrhalis. Levels of lysozyme, lactoferrin, LL-37, and secretory leukocyte protease inhibitor (SLPI) were measured by enzyme-linked immunosorbent assay and compared among groups by paired analysis. RESULTS: Compared with baseline, sputum lysozyme levels were significantly lower during colonization and exacerbation by NTHI (P = .001 and P = .013, respectively) and M catarrhalis (P = .007 and P = .018, respectively); SLPI levels were lower with exacerbation due to NTHI and M catarrhalis (P = .002 and P = .004, respectively), and during colonization by M catarrhalis (P = 032). Lactoferrin levels did not change significantly; LL-37 levels were higher during exacerbation by NTHI and M catarrhalis (P = .001 and P = .018, respectively). CONCLUSIONS: Acquisition of NTHI and M catarrhalis is associated with significant changes in airway levels of AMPs, with larger changes in exacerbation. Airway AMP levels are likely to be important in pathogen clearance and clinical outcomes of infection in COPD.
Authors: Judith von Haussen; Rembert Koczulla; Renat Shaykhiev; Christian Herr; Olaf Pinkenburg; Dietlind Reimer; Rainer Wiewrodt; Stefan Biesterfeld; Achim Aigner; Frank Czubayko; Robert Bals Journal: Lung Cancer Date: 2007-08-31 Impact factor: 5.705
Authors: G Sandra Tjabringa; Dennis K Ninaber; Jan Wouter Drijfhout; Klaus F Rabe; Pieter S Hiemstra Journal: Int Arch Allergy Immunol Date: 2006-03-24 Impact factor: 2.749
Authors: S D Pouwels; I H Heijink; N H T ten Hacken; P Vandenabeele; D V Krysko; M C Nawijn; A J M van Oosterhout Journal: Mucosal Immunol Date: 2013-10-23 Impact factor: 7.313
Authors: Jennifer K Plichta; Steve Droho; Brenda J Curtis; Parita Patel; Richard L Gamelli; Katherine A Radek Journal: Crit Care Med Date: 2014-06 Impact factor: 7.598
Authors: Gimano D Amatngalim; Jasmijn A Schrumpf; Almira Henic; Esther Dronkers; Renate M Verhoosel; Soledad R Ordonez; Henk P Haagsman; Maria E Fuentes; Sriram Sridhar; Jamil Aarbiou; Richard A J Janssen; Annemarie N Lekkerkerker; Pieter S Hiemstra Journal: J Innate Immun Date: 2017-02-08 Impact factor: 7.349
Authors: Patrick Mallia; Joseph Footitt; Rosa Sotero; Annette Jepson; Marco Contoli; Maria-Belen Trujillo-Torralbo; Tatiana Kebadze; Julia Aniscenko; Gregory Oleszkiewicz; Katrina Gray; Simon D Message; Kazuhiro Ito; Peter J Barnes; Ian M Adcock; Alberto Papi; Luminita A Stanciu; Sarah L Elkin; Onn M Kon; Malcolm Johnson; Sebastian L Johnston Journal: Am J Respir Crit Care Med Date: 2012-09-28 Impact factor: 21.405
Authors: Robert M Burkes; Agathe S Ceppe; David J Couper; Alejandro P Comellas; J Michael Wells; Stephen P Peters; Gerard J Criner; Richard E Kanner; Robert Paine; Stephanie A Christenson; Christopher B Cooper; Igor Z Barjaktarevic; Jerry A Krishnan; Wassim W Labaki; MeiLan K Han; Jeffrey L Curtis; Nadia N Hansel; Robert A Wise; M Bradley Drummond Journal: Chronic Obstr Pulm Dis Date: 2020-10